Disc Medicine, Inc.
IRON
Rangering i aksjer
#4957
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Aksjekurs
$75.39
Sist synkronisert: 2026-10-22
Markedsverdi
$2.89B
Endring (1 dag)
-0.80%
Endring (1 år)
-9.92%
Land
US
Handel Disc Medicine, Inc. (IRON)
Kategori
Healthcare
P/B-forhold for Disc Medicine, Inc. (IRON)
P/B-forhold per October 2026 TTM: 4.65
Ifølge Disc Medicine, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 4.65. Ved slutten av 2024 hadde selskapet et P/B-forhold på 3.95.
P/B-historikk for Disc Medicine, Inc. fra 2020 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 4.65 | 22.73% |
| 2025 | 3.79 | -3.98% |
| 2024 | 3.95 | 5.64% |
| 2023 | 3.73 | 3,089.41% |
| 2022 | 0.12 | -132.23% |
| 2021 | -0.36 | -95.22% |
| 2020 | -7.61 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| 6.6964 | 43.96% |
US
|
|
| 13.6307 | 193.03% |
US
|
|
| 4.4521 | -4.29% |
AU
|
|
| 4.2241 | -9.19% |
BE
|
|
| 6.3632 | 36.80% |
NL
|
